Sera Prognostics

IPO

Sera | The Pregnancy Company

Public · Salt Lake City, United States · Founded 2011 · $119.3M raised

Employees
51–200
Founded
2011
Business Model
B2B
Website
sera.com
Total Funding
$119.3M
Last Round
$100.0M Series EApr 2021
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sera Prognostics aims to be a global leader in high-value women's health diagnostics, delivering pivotal information to physicians to improve the health of pregnant women and newborns, and to simultaneously improve health economics. The company offers the PreTRM Test, which predicts a patient's individual risk of spontaneous preterm delivery in asymptomatic singleton pregnancies through a single blood draw performed during weeks 18 through 21 of gestational age. Sera serves healthcare providers, payers, employers, and expectant mothers seeking better prenatal outcomes.

Summary

Sera Prognostics is a Biotech company based in Salt Lake City, United States, founded in 2011. It has raised $119.3M in total across 2 rounds, most recently a $100.0M Series E round in Apr 2021.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOInitial Public OfferingJul 2021
$75.0M

Sign up to see all 3 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sera Prognostics on Indexed.vc
<a href="https://indexed.vc/companies/sera-prognostics"><img src="https://indexed.vc/api/badge/company/sera-prognostics" alt="Sera Prognostics on Indexed.vc" width="260" height="76" /></a>